|

US Pres. Trump: Twinning the Malaria drug with another is looking like good way to fight COVID-19

Following the disappointment from the US Senate, President Donald Trump showed readiness to keep working on the bill while also showing a promising sign of a drug recovery to combat the coronavirus (COVID-19) during Monday’s virus task force conference.

Key quotes

Twinning the Malaria drug with another is looking like good way to fight COVID-19.

We will open up our country fairly soon, ‘not looking at months’.

Will be watching COVID-19 hotspots, even after any easing of current guiding measures.

We will have announcement soon as to timing of measures to ease COVID-19 guidance.

COVID-19 numbers will icrease in time, numbers ‘Going To Be Bad’.

Democrats, Republicans are fairly close to a stimulus deal.

Stimulus Bill still needed because coronavirus has has a big impact on the US economy, even if US reopens.

Government working to obtain large quantities of Chloroquine.

Chloroquine to be distributed in NY tomorrow.

There's a real chance it could have a tremendous impact.

Continuing to work with Republicans and Democrats on capitol hill on stimulus bill.

Will not let cure be worse than the problem.

After 15-day guidance expires, he will decide on how to reopen US economy.

Will not let coronavirus turn into long-lasting financial problem.

Market implications

With the hints of possible drug recovery, the market’s risk-tone turned positive after the news. That said, the US stock futures currently mark close to 1.75% profits despite Wall Street’s losses the previous day.

Author

Anil Panchal

Anil Panchal

FXStreet

Anil Panchal has nearly 15 years of experience in tracking financial markets. With a keen interest in macroeconomics, Anil aptly tracks global news/updates and stays well-informed about the global financial moves and their implications.

More from Anil Panchal
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD recovers to 1.1750 region as 2025 draws to a close

Following the bearish action seen in the European session on Wednesday, EUR/USD regains its traction and recovery to the 1.1750 region. Nevertheless, the pair's volatility remains low as trading conditions thin out on the last day of the year.

GBP/USD stays weak near 1.3450 on modest USD recovery

GBP/USD remains under modest beairsh pressure and fluctuates at around 1.3450 on Wednesday. The US Dollar finds fresh demand due to the end-of-the-year position adjustments, weighing on the pair amid the pre-New Year trading lull. 

Gold retreats to $4,300 area, looks to post monthly gains

Gold stays on the back foot on the last day of 2025 and trades near $4,300, possibly pressured by profit-taking and position adjustments. Nevertheless, XAU/USD remains on track to post gains for December and extend its winning streak into a fifth consecutive month.

Bitcoin, Ethereum and XRP prepare for a potential New Year rebound

Bitcoin, Ethereum, and Ripple are holding steady on Wednesday after recording minor gains on the previous day. Technically, Bitcoin could extend gains within a triangle pattern while Ethereum and Ripple face critical overhead resistance. 

Economic outlook 2026-2027 in advanced countries: Solidity test

After a year marked by global economic resilience and ending on a note of optimism, 2026 looks promising and could be a year of solid economic performance. In our baseline scenario, we expect most of the supportive factors at work in 2025 to continue to play a role in 2026.

Crypto market outlook for 2026

Year 2025 was volatile, as crypto often is.  Among positive catalysts were favourable regulatory changes in the U.S., rise of Digital Asset Treasuries (DAT), adoption of AI and tokenization of Real-World-Assets (RWA).